Epidiolex

2 Blockbuster New Drug Launches Making Investors Nervous Right Now
Motley Fool
Sun, 08/26/18 - 12:01 pm
drug launches
Alnylam
GW Pharma
Onpattro
Epidiolex
These Epilepsy Drugmakers Are About to Brawl
Motley Fool
Thu, 07/19/18 - 11:30 pm
epilepsy
Zogenix
ZX008
GW Pharma
Epidiolex
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
Xconomy
Thu, 07/12/18 - 09:59 am
Dravet syndrome
clinical trials
Zogenix
ZX008
FenPhen
GW Pharma
Epidiolex
Berkeley boy was ‘Patient X’ in first FDA-approved medicine derived from marijuana
San Francisco Chronicle, CA
Mon, 07/9/18 - 10:01 pm
patients
clinical trials
GW Pharma
Epidiolex
seizures
CBD
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
CP Wire
Mon, 07/2/18 - 04:56 pm
CBD
Epidiolex
GW Pharma
FDA
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
Tue, 07/3/18 - 02:05 pm
CBD
Epidiolex
GW Pharma
FDA
FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions
Medical Marketing and Media
Tue, 06/26/18 - 10:17 pm
FDA
GW Pharma
Epidiolex
epilepsy
CBD
drug pricing
DEA
FDA approves country’s first medicine made from marijuana
Stat
Mon, 06/25/18 - 12:51 pm
GW Pharma
Epidiolex
epilepsy
FDA
Dravet syndrome
Lennox-Gastaut Syndrome
marijuana
3 Biotechs With Huge FDA Decisions in June
Motley Fool
Thu, 05/31/18 - 10:00 pm
biotech
Array Biopharma
encorafenib
binimetinib
GW Pharma
Epidiolex
Incyte
olumiant
This Cannabis-Based Drug Is On the Verge of Making History
Motley Fool
Sun, 05/20/18 - 08:40 pm
GW Pharma
Epidiolex
CBD
Dravet syndrome
Lennox-Gastaut Syndrome
FDA
A look at The First Company Likely to Market an FDA Approved Cannabinoid in the US
CP Wire
Mon, 04/30/18 - 06:47 pm
GW Pharma
Epidiolex
FDA
cannabinoids
FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
Forbes
Thu, 04/19/18 - 11:52 pm
FDA
GW Pharma
Epidiolex
epilepsy
advisory panels
GW Pharma riding high as cannabinoid Epidiolex nears first U.S. approval
Fierce Biotech
Wed, 04/18/18 - 09:33 am
GW Pharma
Epidiolex
FDA
epilepsy
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
Wed, 02/21/18 - 11:00 pm
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
A Tiny Biotech Just Dealt a Big Blow to Marijuana's Use in Epilepsy
Motley Fool
Mon, 10/2/17 - 11:09 am
biotech
marijuana
epilepsy
ZX008
Zogenix
Epidiolex
GW Pharma
seizures
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Motley Fool
Tue, 06/6/17 - 09:35 am
Zogenix
GW Pharma
Sativex
Epidiolex
LGS
Dravet syndrome

Pages